Dalbavancin / Oritavancin / Telavancin
Also referenced as: Dalvance, Orbactiv, Vibativ
A family overview of three distinct lipoglycopeptide antibiotics, not a research blend.
- Evidence grade
- AStrong Clinical Evidence
Strong Clinical Evidence
- Regulatory status
- FDA Approved for Specific Indication
FDA-approved medicines with distinct populations and indications. This grouped overview does not describe a combined product or a universal infection treatment.
- Human data
- Yes
Registered clinical trials exist
- Last reviewed
- October 27, 2026
Overview
A family overview of three distinct lipoglycopeptide antibiotics, not a research blend.
FDA-approved medicines with distinct populations and indications. This grouped overview does not describe a combined product or a universal infection treatment.
They are not interchangeable. Oritavancin interferes with coagulation tests; telavancin pneumonia use is restricted when alternatives are unsuitable.
Why It's Being Studied
- Bacterial skin infections
- Antimicrobial mechanisms
Mechanism of Action
These antibiotics inhibit Gram-positive bacterial cell-wall synthesis; oritavancin and telavancin also have membrane effects.
These antibiotics inhibit Gram-positive bacterial cell-wall synthesis; oritavancin and telavancin also have membrane effects. They are not interchangeable. Oritavancin interferes with coagulation tests; telavancin pneumonia use is restricted when alternatives are unsuitable.
From molecular target to clinical evidence
Tap each stage to see what happens.
Background: Clinical Peptide Medicines
Clinical peptide medicines include endocrine treatments, antimicrobial drugs, receptor blockers and targeted diagnostic or cancer agents. They do not share one mechanism or one set of indications.
An approval belongs to a specific medicine and indication. A diagnostic tracer, an antibiotic and a hormone are not interchangeable wellness products; read each profile's own mechanism and prescribing source.
Research Areas & Routes Studied
- Bacterial skin infections
- Antimicrobial mechanisms
- Intravenous approved medicines
Evidence Summary
Each has human antibacterial evidence and product-specific approved indications. Dalbavancin and oritavancin treat defined skin infections; telavancin also has a restricted pneumonia indication.
Higher tiers carry more weight. Filled tiers have evidence for Dalbavancin / Oritavancin / Telavancin; tap to read it.
- Each has human antibacterial evidence and product-specific approved indications. Dalbavancin and oritavancin treat defined skin infections; telavancin also has a restricted pneumonia indication.
3 cited sources.
- Prescribing label3
Human clinical evidence
- Each has human antibacterial evidence and product-specific approved indications. Dalbavancin and oritavancin treat defined skin infections; telavancin also has a restricted pneumonia indication.
Reported Adverse Events in Research
- Risks differ: hypersensitivity and infusion reactions, coagulation-test interference with oritavancin, and renal/fetal toxicity with telavancin.
Limitations of Current Evidence
- They are not interchangeable. Oritavancin interferes with coagulation tests; telavancin pneumonia use is restricted when alternatives are unsuitable.
- Findings apply to the product, route and population studied; they do not establish benefits or safety for unrelated wellness uses or research-vial products.
How to Read This Research
- Is this a single molecule or a family of medicines?
- Is the use diagnostic, therapeutic or investigational?
- Does the quoted outcome match the exact product, formulation and population?
- Use the compound-specific mechanism above; this diagram describes drug development, not a shared biological pathway.
- Historical approval, present availability and off-label use are distinct questions.
- For radiopharmaceuticals and hospital medicines, specialist handling is part of the treatment context.
- Indication
- The condition and population for which a medicine is approved.
- Antagonist
- A compound that blocks activity at a receptor.
- Radiopharmaceutical
- A medicine containing a radioactive isotope for imaging or treatment.
Compare With Other Compounds
| Dalbavancin / Oritavancin / Telavancin | Trofinetide | |
|---|---|---|
| Evidence grade | A — Strong Clinical Evidence | B — Moderate Human Evidence |
| Regulatory status | FDA Approved for Specific Indication | FDA Approved for Specific Indication |
| Human data | Yes | Yes |
| Clinical trials | Registered trials exist | Registered trials exist |
| Research routes | Intravenous approved medicines | Oral approved medicine |
| Cited sources | 3 | 2 |
Frequently Asked Questions
Research References
- Prescribing label
Dalbavancin / Oritavancin / Telavancin — prescribing label
- Prescribing label
Oritavancin label
- Prescribing label
Telavancin label